Piramal Pharma Limited — Others, 21-10-2024: Action(s) taken or orders passed

Piramal Pharma Limited reported receiving a compounding order regarding a ₹70,000 fee for alleged violations related to product information disclosure on its e-commerce platform. The company stated that this order will not materially impact its financials, operations, or activities.